These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19952711)

  • 1. Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease?
    Jarvis JN; Harrison TS; Corbett EL; Wood R; Lawn SD
    AIDS; 2010 Feb; 24(4):612-4. PubMed ID: 19952711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.
    Hiesgen J; Schutte C; Olorunju S; Retief J
    Int J STD AIDS; 2017 Apr; 28(5):480-485. PubMed ID: 27255493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.
    Jarvis JN; Boulle A; Loyse A; Bicanic T; Rebe K; Williams A; Harrison TS; Meintjes G
    AIDS; 2009 Jun; 23(9):1182-3. PubMed ID: 19451796
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings.
    Kendi C; Penner J; Koech J; Nyonda M; Cohen CR; Bukusi EA; Ngugi E; Meyer AC
    Postgrad Med J; 2013 Feb; 89(1048):73-7. PubMed ID: 23112217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of highly active antiretroviral therapy leads to cryptococcal meningitis/choroiditis in an AIDS patient.
    Chronister CL
    Optometry; 2006 Sep; 77(9):438-45. PubMed ID: 16939885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of AIDS-associated cryptomeningitis.
    Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
    Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
    Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.
    Katchanov J; Branding G; Jefferys L; Arastéh K; Stocker H; Siebert E
    Int J STD AIDS; 2016 Feb; 27(2):110-7. PubMed ID: 25693580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa.
    Stadelman AM; Ssebambulidde K; Tugume L; Pastick KA; Hullsiek KH; Lofgren S; Nuwagira E; Evans EE; Williams DA; Muzoora C; Meya DB; Rajasingham R; Rhein J; Boulware DR
    Med Mycol; 2021 Jul; 59(7):712-719. PubMed ID: 33399865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
    Komati S; Shaw PA; Stubbs N; Mathibedi MJ; Malan L; Sangweni P; Metcalf JA; Masur H; Hassim S
    AIDS; 2010 Jul; 24(12):1849-55. PubMed ID: 20622529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients.
    Moosa MY; Coovadia YM
    Clin Infect Dis; 1997 Feb; 24(2):131-4. PubMed ID: 9114135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.
    Jarvis JN; Lawn SD; Vogt M; Bangani N; Wood R; Harrison TS
    Clin Infect Dis; 2009 Apr; 48(7):856-62. PubMed ID: 19222372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
    Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
    Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
    Wadhwa A; Kaur R; Bhalla P
    Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual infective pathology in patients with cryptococcal meningitis.
    Silber E; Sonnenberg P; Koornhof HJ; Morris L; Saffer D
    Neurology; 1998 Oct; 51(4):1213-5. PubMed ID: 9781566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
    Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
    Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
    Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
    Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
    J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.